文献速递胸部CT

定量影像生物标志物在临床胸部CT中的转化应用

Translation of Quantitative Imaging Biomarkers into Clinical Chest CT.
PubMed 文献 · Radiographics · 2019-06-14

本文由RSNA发布,介绍定量影像生物标志物联盟(QIBA)旨在通过减少设备、站点、患者和时间间的变异,提升定量影像生物标志物的价值与实用性;胸部CT因使用频率高且涵盖全球主要死因,在该计划中占据战略地位。文中阐述QIBA已针对胸部CT肺病灶体积测量的准确、可重复和有意义的应用制定规范,并讨论慢性阻塞性肺疾病肺实质与气道改变评估、双能CT灌注生物标志物分析以及机会性筛查冠状动脉粥样硬化和低骨量等即将从研究转化为临床的定量方法。

要点

  • QIBA致力于通过减少设备、站点、患者和时间间的变异,提升定量影像生物标志物的价值与实用性。
  • 胸部CT因使用频率高且解剖上涵盖全球主要死因,在QIBA计划中占据战略地位。
  • QIBA已制定针对胸部CT肺病灶体积测量准确、可重复和有意义的应用的规范。

核心结论

  • 定量影像生物标志物在胸部CT中的临床转化正在推进,QIBA已针对肺病灶体积测量制定规范,其他定量方法(COPD肺实质与气道改变评估、双能CT灌注分析、机会性筛查冠状动脉粥样硬化和低骨量)即将从研究转化为临床实践。

研究设计与样本

  • 本文为RSNA(Radiological Society of North America)发布的综述,介绍定量影像生物标志物联盟(QIBA)的倡议背景、胸部CT的战略地位、已制定的肺病灶体积测量规范,以及即将转化应用的定量方法;原文未报告系统检索范围与纳入文献。

诊断标准与关键数值

  • QIBA已制定针对胸部CT中肺病灶体积测量准确、可重复和有意义的应用的规范。
  • 其他即将转化的定量方法包括:慢性阻塞性肺疾病患者肺实质与气道改变的评估;双能CT灌注生物标志物分析;利用因其他指征行胸部CT的机会性筛查冠状动脉粥样硬化和低骨量。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Quantitative imaging has been proposed as the next frontier in radiology as part of an effort to improve patient care through precision medicine. In 2007, the Radiological Society of North America launched the Quantitative Imaging Biomarkers Alliance (QIBA), an initiative aimed at improving the value and practicality of quantitative imaging biomarkers by reducing variability across devices, sites, patients, and time. Chest CT occupies a strategic position in this initiative because it is one of the most frequently used imaging modalities, anatomically encompassing the leading causes of mortality worldwide. To date, QIBA has worked on profiles focused on the accurate, reproducible, and meaningful use of volumetric measurements of lung lesions in chest CT. However, other quantitative methods are on the verge of translation from research grounds into clinical practice, including (a) assessment of parenchymal and airway changes in patients with chronic obstructive pulmonary disease, (b) analysis of perfusion with dual-energy CT biomarkers, and (c) opportunistic screening for coronary atherosclerosis and low bone mass by using chest CT examinations performed for other indications. The rationale for and the key facts related to the application of these quantitative imaging biomarkers in cardiothoracic chest CT are presented. ©RSNA, 2019 See discussion on this article by Buckler (pp 977-980).

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Kay FU, Oz OK, Abbara S, et al. Translation of Quantitative Imaging Biomarkers into Clinical Chest CT. Radiographics. 2019. PMID: 31199712. doi:10.1148/rg.2019180168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。